Journal of Cancer Treatment and Research

| Peer-Reviewed |

Colour Doppler-An Evaluation Tool for Assessment of Breast Tumour Size, Axillary Lymph Node Size and Chemotherapeutic Response

Received: 08 March 2014    Accepted:     Published: 30 March 2014
Views:       Downloads:

Share This Article

Abstract

Aims: The present study was taken up in carcinoma breast patients to evaluate clinical examination and Colour Doppler in estimating the breast tumour size, axillary lymph node size and chemotherapeutic response, taking histopathological examination as the gold standard. Material & Methods: The study carried out between December 2008 to June 2010 included 37 patients. Ethics committee clearance obtained. Chemotherapeutic response could be assessed in 24 patients who received chemotherapy prior to surgery. 13 patients were taken up directly for surgery. Clinical, sonological and histopathological largest dimension of the primary tumour and axillary lymph nodes were assessed. Chemotherapy response grades were assessed as per criteria given by Kumar A et al. Results were analyzed using paired-t test, weighted kappa and Spearman correlation coefficient. Results: The difference between mean clinical and histopathological size of breast tumour of 0.01cm, was statistically not significant (t=.064, p=.949). However, the difference between mean sonological and histopathological size of breast tumour of 1.10cm, was statistically highly significant (t=-3.93, p<.001). For axillary lymph nodes, the mean difference between clinical and histopathological assessment was 0.46 cm (p=0.007) as against mean difference of 0.48 cm between sonological and histopathological assessment (p=0.001). Clinical response showed substantial agreement with histopathological response in breast tumour (k=0.657; p=0.001) and axillary lymph nodes (k=0.62; p<0.005). Sonological response showed moderate agreement (k=0.510; p< 0.02) in breast tumour and substantial agreement (k=0.691; p<0.001) in axillary lymph nodes. Compared to histopathological response, RI, PI and Vmax response showed moderate agreement in primary and substantial agreement in axillary lymph nodes. Conclusion: In the present study, sonology was found to be a poor modality for breast tumour size, axillary lymph node size estimation. With regard to chemotherapy response assessment, clinical examination was a better modality for primary, while Colour Doppler was better for axillary lymph node evaluation.

DOI 10.11648/j.jctr.20140202.11
Published in Journal of Cancer Treatment and Research (Volume 2, Issue 2, March 2014)
Page(s) 9-15
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Colour Doppler, Chemotherapeutic Response, Breast Cancer

References
[1] Veronesi U, Galimberti V, Zurrida S, Pigatto F, Veronesi P, Robertson C, Paganelli G, Sciascia V, Viale G. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001;37:454-8.
[2] Cowen D, Jacquemier J, Houvenaeghel G, Viens P, Puig B, Bardou VJ, Resbeut M, Maraninchi D. Local and distant recurrence after conservative management of ‘very low-risk’ breast cancer are dependent events: a 10-year follow-up. Int J Radiat Oncol Biol Phys 1998;41:801-7.
[3] Dongen van JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, Schueren van der E, Sylvester R, Tong D, Winter J, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992;28A(4-5):801-5.
[4] Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181-7.
[5] Sobin LH, Wittekind C. TNM Classification of malignant tumours, Breast Tumours (ICD-O C50) 1997.
[6] Critical assessment of the clinical TNM system in breast cancer. Report from the Yorkshire Breast Cancer Group, Br. Med. J. 1980; 281: 134-6.
[7] Hortobagyi GN. Developments in chemotherapy of breastcancer. Cancer 2000; 88 (Suppl-12):3073-3079.
[8] Bonadona G, Valgussa P, Brambilla C, Moliterni A, Zambetti M, Ferrari LS. Adjuvant and neoadjuvant treatment of breast cancers with chemotherapy and endocrine therapy. Semin Oncol 1991; 18: 515-24.
[9] Smith IE, Powel TJ, Martin Dunitz. Medical management of breast cancer primary medical therapy. London 1991; 259.
[10] . Dixon JM, Senbanjo RO, Anderson TJ, Forrest AP, Elton RA: Clinical assessment of tumour size in primary breast carcinoma. Clin Oncol 10:117-121, 1984.
[11] Forouhi P, Walsh JS, Anderson TJ, Chetty U: Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment. BrJ Surg 81:223-225, 1994.
[12] Fornage BD, Toubas O, Morel M: Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer 60:765-771, 1987.
[13] Dixon JM, Walsh J, Paters M, Chetty U. Color Doppler ultrasound studies of benign and malignant lesions. Br J Surg 1992; 79: 259-60.
[14] Kumar Anand, Srivastava Vivek, Singh Seema & Shukla RC. Color Doppler ultrasonography for treatment response prediction and evaluation in breast cancer. Future Oncology 2010; 6(8): 1265-1278.
[15] Singh S, Pradhan S, Shukla RC, Ansari MA, Kumar A: Color Doppler ultrasound as an objective assessment tool for chemotherapeutic response in advanced breast cancer. Breast Cancer 2005, 12:45-51.
[16] Kumar A, Singh S, Pradhan S, Shukla RC, Ansari MA, Singh TB, Shyam Rohit and Gupta Saroj. Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer. World Journal of Surgical Oncology 2007, 5:99.
[17] Nair MK, Varghese C, Swaminathan A. Cancer: Current scenario intervention strategies and projections for 2015. Burden of disease in India. Background papers. National Commission for Macroeconomics and health, Ministry of Health and Family Welfare, Government of India, New Delhi. Pp. 218-25, 2005.
[18] Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg. 1985; 202:702–707.
[19] S.K. Apple, F. Suthar. How do we measure a residual tumor size in Histopathology (the gold standard) after neoadjuvant chemotherapy? The Breast 2006; 15: 370–376.
[20] Chagpar A, Middleton L, Sahin A, et al. Accuracy of physical examination, untrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 2006; 243: 257–264.
[21] Viviana Londero, Massimo Bazzocchi, Chiara Del Frate, Fabio Puglisi, Carla Di Loreto,Giuliana Francescutti, Chiara Zuiani: Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 2004; 14:1371–1379.
[22] Cheong Shook Lee, Jin-Gu Bong, Jin-Hyun Park, Yoon Sik Lee, Sun-Mi Paik, et al., The accuracy of the physical examination, mammography and ultrasonography in the assessment of tumor size and axillary lymph node metastasis in breast cancer patient serve as use adjuncts to sentinel node biopsy. Journal of Korean Breast Cancer Society 2003; 6: 87-94.
[23] Raquel Prati, Christina A. Minami, Jeff A. Gornbein, Accuracy of Clinical Evaluation of Locally Advanced Breast Cancer in Patients Receiving Neoadjuvant Chemotherapy. Cancer. 2009; 115(6):1194–1202.
[24] Sabel M, Aichuinger H: Recent developments in breast imaging. Phy Med Biol 1996; 41:315-368.
[25] Kubota K, Hisa N, Ogawa Y, Shoji Y: Evaluation of tissue harmonic imaging for breast tumors and axillary lymph nodes. Oncology Rep 2002; 9:1335-1338.
[26] Newman LA, Pernick NL, Adsay V, et al: Histopathologic evidence of tumor regression in the axillary lymph nodes of patients treated with preoperative chemotherapy correlates with breast cancer outcome. Ann Surg Oncol 2003; 10:734-739.
[27] Caruso G, Cucciarre S, Lo Bello M, Mercurio G, Candela F, Cianchino C, Lagalla R. Neoadjuvant intralesional chemotherapy for breast neoplasm in advanced stage. Assessment of its efficacy with Doppler color. Radiol Med (Torino) 1995;89(5):613– 618.
[28] Lagalla R, Caruso G, Finazzo M: Monitoring treatment response with color and power Doppler. Eur J Radiol 1998; 27(Suppl 2):149-156.
[29] Kedar RP, Cosgrove DO, Smith IE, et al. Breast carcinoma: Measurement of tumour response to primary medical therapy with color Doppler flow imaging. Radiology 1994; 190(3): 825-30.
[30] Roberrto L, Giuseppe C, Mario F. Monitoring treatment response with color and power Doppler. Eur J Radiol 1998; 28: S149 –156.
[31] Singh Gurpreet, Kumara Pratik, Parshadb Rajinder, Seith Ashu, Thulkar Sanjay, Hostend Norbert. Role of color Doppler indices in predicting disease-free survival of breast cancer patients during neoadjuvant chemotherapy. European Journal of Radiology 2009.
[32] Huber S, Medl M, Helbich T, Taucher S, Wagner T, et al: Locally advanced breast carcinoma: Computer assisted semi quantitative analysis of Color Doppler ultrasonography in the evaluation of tumor response to neoadjuvant chemotherapy. J Ultrasound Med 2000; 19:601-607.
[33] Berna Öksüzoğlu, Murat Vural, Hüseyin Abalı, Mesude Yılmaz, Nuriye Yıldırım, Nurullah Zengin. Blood Flow Indices by Doppler Ultrasonography Vary with Neoadjuvant Chemotherapy but Are Not Related to Plasma VEGF Levels in Locally Advanced Breast Cancer. Oncology 2006; 71: 185-189.
Author Information
  • Departments of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

  • Departments of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

  • Departments of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

  • Departments of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

  • Department of Radiodiagnosis & Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

  • Departments of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

  • Departments of Radiotherapy and Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

Cite This Article
  • APA Style

    Rashmi Singh, Govardhan H. B., Satyajt Pradhan, Anand Kumar, R. C. Shukla, et al. (2014). Colour Doppler-An Evaluation Tool for Assessment of Breast Tumour Size, Axillary Lymph Node Size and Chemotherapeutic Response. Journal of Cancer Treatment and Research, 2(2), 9-15. https://doi.org/10.11648/j.jctr.20140202.11

    Copy | Download

    ACS Style

    Rashmi Singh; Govardhan H. B.; Satyajt Pradhan; Anand Kumar; R. C. Shukla, et al. Colour Doppler-An Evaluation Tool for Assessment of Breast Tumour Size, Axillary Lymph Node Size and Chemotherapeutic Response. J. Cancer Treat. Res. 2014, 2(2), 9-15. doi: 10.11648/j.jctr.20140202.11

    Copy | Download

    AMA Style

    Rashmi Singh, Govardhan H. B., Satyajt Pradhan, Anand Kumar, R. C. Shukla, et al. Colour Doppler-An Evaluation Tool for Assessment of Breast Tumour Size, Axillary Lymph Node Size and Chemotherapeutic Response. J Cancer Treat Res. 2014;2(2):9-15. doi: 10.11648/j.jctr.20140202.11

    Copy | Download

  • @article{10.11648/j.jctr.20140202.11,
      author = {Rashmi Singh and Govardhan H. B. and Satyajt Pradhan and Anand Kumar and R. C. Shukla and U. P. Shahi and L. M. Agrawal},
      title = {Colour Doppler-An Evaluation Tool for Assessment of Breast Tumour Size, Axillary Lymph Node Size and Chemotherapeutic Response},
      journal = {Journal of Cancer Treatment and Research},
      volume = {2},
      number = {2},
      pages = {9-15},
      doi = {10.11648/j.jctr.20140202.11},
      url = {https://doi.org/10.11648/j.jctr.20140202.11},
      eprint = {https://download.sciencepg.com/pdf/10.11648.j.jctr.20140202.11},
      abstract = {Aims: The present study was taken up in carcinoma breast patients to evaluate clinical examination and Colour Doppler in estimating the breast tumour size, axillary lymph node size and chemotherapeutic response, taking histopathological examination as the gold standard. Material & Methods: The study carried out between December 2008 to June 2010 included 37 patients. Ethics committee clearance obtained. Chemotherapeutic response could be assessed in 24 patients who received chemotherapy prior to surgery. 13 patients were taken up directly for surgery. Clinical, sonological and histopathological largest dimension of the primary tumour and axillary lymph nodes were assessed. Chemotherapy response grades were assessed as per criteria given by Kumar A et al. Results were analyzed using paired-t test, weighted kappa and Spearman correlation coefficient. Results: The difference between mean clinical and histopathological size of breast tumour of 0.01cm, was statistically not significant (t=.064, p=.949). However, the difference between mean sonological and histopathological size of breast tumour of 1.10cm, was statistically highly significant (t=-3.93, p<.001). For axillary lymph nodes, the mean difference between clinical and histopathological assessment was 0.46 cm (p=0.007) as against mean difference of 0.48 cm between sonological and histopathological assessment (p=0.001). Clinical response showed substantial agreement with histopathological response in breast tumour (k=0.657; p=0.001) and axillary lymph nodes (k=0.62; p<0.005). Sonological response showed moderate agreement (k=0.510; p< 0.02) in breast tumour and substantial agreement (k=0.691; p<0.001) in axillary lymph nodes. Compared to histopathological response, RI, PI and Vmax response showed moderate agreement in primary and substantial agreement in axillary lymph nodes. Conclusion: In the present study, sonology was found to be a poor modality for breast tumour size, axillary lymph node size estimation. With regard to chemotherapy response assessment, clinical examination was a better modality for primary, while Colour Doppler was better for axillary lymph node evaluation.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Colour Doppler-An Evaluation Tool for Assessment of Breast Tumour Size, Axillary Lymph Node Size and Chemotherapeutic Response
    AU  - Rashmi Singh
    AU  - Govardhan H. B.
    AU  - Satyajt Pradhan
    AU  - Anand Kumar
    AU  - R. C. Shukla
    AU  - U. P. Shahi
    AU  - L. M. Agrawal
    Y1  - 2014/03/30
    PY  - 2014
    N1  - https://doi.org/10.11648/j.jctr.20140202.11
    DO  - 10.11648/j.jctr.20140202.11
    T2  - Journal of Cancer Treatment and Research
    JF  - Journal of Cancer Treatment and Research
    JO  - Journal of Cancer Treatment and Research
    SP  - 9
    EP  - 15
    PB  - Science Publishing Group
    SN  - 2376-7790
    UR  - https://doi.org/10.11648/j.jctr.20140202.11
    AB  - Aims: The present study was taken up in carcinoma breast patients to evaluate clinical examination and Colour Doppler in estimating the breast tumour size, axillary lymph node size and chemotherapeutic response, taking histopathological examination as the gold standard. Material & Methods: The study carried out between December 2008 to June 2010 included 37 patients. Ethics committee clearance obtained. Chemotherapeutic response could be assessed in 24 patients who received chemotherapy prior to surgery. 13 patients were taken up directly for surgery. Clinical, sonological and histopathological largest dimension of the primary tumour and axillary lymph nodes were assessed. Chemotherapy response grades were assessed as per criteria given by Kumar A et al. Results were analyzed using paired-t test, weighted kappa and Spearman correlation coefficient. Results: The difference between mean clinical and histopathological size of breast tumour of 0.01cm, was statistically not significant (t=.064, p=.949). However, the difference between mean sonological and histopathological size of breast tumour of 1.10cm, was statistically highly significant (t=-3.93, p<.001). For axillary lymph nodes, the mean difference between clinical and histopathological assessment was 0.46 cm (p=0.007) as against mean difference of 0.48 cm between sonological and histopathological assessment (p=0.001). Clinical response showed substantial agreement with histopathological response in breast tumour (k=0.657; p=0.001) and axillary lymph nodes (k=0.62; p<0.005). Sonological response showed moderate agreement (k=0.510; p< 0.02) in breast tumour and substantial agreement (k=0.691; p<0.001) in axillary lymph nodes. Compared to histopathological response, RI, PI and Vmax response showed moderate agreement in primary and substantial agreement in axillary lymph nodes. Conclusion: In the present study, sonology was found to be a poor modality for breast tumour size, axillary lymph node size estimation. With regard to chemotherapy response assessment, clinical examination was a better modality for primary, while Colour Doppler was better for axillary lymph node evaluation.
    VL  - 2
    IS  - 2
    ER  - 

    Copy | Download

  • Sections